Cosmetic Toxicologists are experts who rigorously evaluate the safety of ingredients and finished products in the cosmetics industry. They conduct comprehensive toxicological assessments to identify potential risks such as skin irritation, allergic reactions, phototoxicity, and systemic toxicity. By analyzing data from laboratory tests, computer models, and clinical studies, they provide critical insights that ensure cosmetic products are safe for consumer use. These professionals work closely with product developers, regulatory authorities, and quality assurance teams to guarantee that formulations comply with global safety standards, including FDA and EU regulations.
Beyond assessing risks, cosmetic toxicologists also play a pivotal role in innovating safer ingredient alternatives and developing non-animal testing methodologies. They help guide product labeling and safety communication to protect consumers and foster transparency. Their expertise not only supports regulatory compliance but also drives the industry toward sustainable and health-conscious cosmetic solutions. By combining scientific rigor with regulatory knowledge, cosmetic toxicologists safeguard public health while enabling the creation of effective, trustworthy cosmetic products. Their work is essential for maintaining consumer confidence and advancing safety in the beauty industry.
Title : Paraneoplastic autoimmune multiorgan syndrome or PAMS: Paraneoplastic pemphigus revisited
Sergei A Grando, University of California Irvine, United States
Title : Modern non-invasive methods for in vivo assessment of skin
Georgios N Stamatas, SGS, France
Title : Personalized and precision dermatology through the view of biodesign-inspired translational & data-driven applications: Revolutionary skin treatments for every concern in clinical dermatology integrating skin care experts and consumers
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : The next generation of threads: Lifting, volumization, and biostimulation in one powerful triple action
George Sulamanidze, Plastic Surgeon at Clinic of Plastic and Aesthetic Surgery and Cosmetology TOTALCharm, Georgia
Title : Lymphoproliferative diseases in the practice of a dermatologist
Irina Sergeeva, Novosibirsk State University, Russian Federation
Title : Comparative efficacy of omalizumab and dupilumab in children with Chronic Spontaneous Urticaria (CSU): A retrospective cohort analysis
Molynna Nguyen, University of Toledo, United States
Title : "Mirror mirror on the skin” — A low-cost community strategy to reduce melanoma disparities in Washington, D.C.
Kayla Sampson, Georgetown University School of Medicine, United States
Title : Vitiligo: Not just an aesthetic disorder
Mateja Starbek Zorko, University Medical centre Ljubljana, Slovenia
Title : Personalized and precision medicine as a unique avenue to have the healthcare model renewed to secure the national biosafety: Advanced skincare solutions in individualized cosmetology, reconstructive plastic surgery and the modern beauty
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Keratinocyte apoptosis by caspase – 3 Immunostaining in histopathology as marker of activity as well as correlation with dermoscopy findings in Cutaneous Lupus Erythematosus (CLE) in skin of color: An observational study.
Subhojit Ray, All India Institute of Medical Sciences, India